Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 4 of the 13 calendar months from Oct 2025 to Oct 2026: Jan 2026, Feb 2026, Mar 2026 and Jul 2026.
- Largest single sale: $5.7M (71,600 shares) of Ionis Pharmaceuticals Inc on Mar 3, 2026. Filing
- Last sale before this period: Sep 5, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Ionis Pharmaceuticals Inc (IONS) | EVP, Chief Scientific Officer | Jan 5, 2004 | Sep 2, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 31, 2026, Ionis Pharmaceuticals Inc: 110 shares in other transactions. 1 filing: 1
- Jul 7, 2026, Ionis Pharmaceuticals Inc: sold 20,536 shares for $1.7M, under a disclosed plan; 15,000 shares in other transactions (some held indirectly). 1 filing: 1
- Mar 3, 2026, Ionis Pharmaceuticals Inc: sold 85,089 shares for $6.7M, under a disclosed plan; 65,089 shares acquired by exercising options. 1 filing: 1
- Feb 27, 2026, Ionis Pharmaceuticals Inc: 261 shares in other transactions. 1 filing: 1
- Feb 2, 2026, Ionis Pharmaceuticals Inc: sold 85,089 shares for $7.1M, under a disclosed plan; 65,089 shares acquired by exercising options; 0 shares in other transactions. 2 filings: 1, 2
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.